vs
Side-by-side financial comparison of CAMDEN NATIONAL CORP (CAC) and ImmunityBio, Inc. (IBRX). Click either name above to swap in a different company.
CAMDEN NATIONAL CORP is the larger business by last-quarter revenue ($64.3M vs $38.3M, roughly 1.7× ImmunityBio, Inc.). CAMDEN NATIONAL CORP runs the higher net margin — 34.0% vs -161.8%, a 195.8% gap on every dollar of revenue.
Camden National Bank is a commercial bank headquartered in Camden, Maine, operating as the principal subsidiary of Camden National Corporation, a publicly traded bank holding company. Founded in 1875, the bank became a direct, wholly owned subsidiary of the holding company following a corporate reorganization in 1984. Following the 2025 merger with Northway Financial, the combined institution has approximately $7.0 billion in assets.
ImmunityBio, Inc. is a clinical-stage biotechnology company focused on developing next-generation immunotherapies and vaccine candidates targeting multiple cancer types and infectious diseases. It operates mainly in the U.S. market, with core R&D segments including cell therapy, antibody therapeutics, and targeted vaccine platforms designed to enhance patient treatment outcomes.
CAC vs IBRX — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $64.3M | $38.3M |
| Net Profit | $21.9M | $-61.9M |
| Gross Margin | — | 99.0% |
| Operating Margin | — | -169.0% |
| Net Margin | 34.0% | -161.8% |
| Revenue YoY | — | 407.0% |
| Net Profit YoY | — | -4.7% |
| EPS (diluted) | $1.29 | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $64.3M | — | ||
| Q4 25 | $68.1M | $38.3M | ||
| Q3 25 | $65.4M | $32.1M | ||
| Q2 25 | $62.3M | $26.4M | ||
| Q1 25 | $60.1M | $16.5M | ||
| Q4 24 | $47.6M | $7.6M | ||
| Q3 24 | $45.0M | $6.1M | ||
| Q2 24 | $42.8M | — |
| Q1 26 | $21.9M | — | ||
| Q4 25 | $22.6M | $-61.9M | ||
| Q3 25 | $21.2M | $-67.3M | ||
| Q2 25 | $14.1M | $-92.6M | ||
| Q1 25 | $7.3M | $-129.6M | ||
| Q4 24 | $14.7M | $-59.2M | ||
| Q3 24 | $13.1M | $-85.7M | ||
| Q2 24 | $12.0M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | 99.0% | ||
| Q3 25 | — | 99.4% | ||
| Q2 25 | — | 99.5% | ||
| Q1 25 | — | 99.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | 41.5% | -169.0% | ||
| Q3 25 | 40.5% | -173.5% | ||
| Q2 25 | 28.5% | -269.8% | ||
| Q1 25 | 10.3% | -390.1% | ||
| Q4 24 | 38.7% | -919.0% | ||
| Q3 24 | 35.2% | -1314.3% | ||
| Q2 24 | 34.7% | — |
| Q1 26 | 34.0% | — | ||
| Q4 25 | 33.1% | -161.8% | ||
| Q3 25 | 32.4% | -209.8% | ||
| Q2 25 | 22.6% | -350.3% | ||
| Q1 25 | 12.2% | -784.9% | ||
| Q4 24 | 30.8% | -783.4% | ||
| Q3 24 | 29.1% | -1404.0% | ||
| Q2 24 | 28.0% | — |
| Q1 26 | $1.29 | — | ||
| Q4 25 | $1.33 | $-0.06 | ||
| Q3 25 | $1.25 | $-0.07 | ||
| Q2 25 | $0.83 | $-0.10 | ||
| Q1 25 | $0.43 | $-0.15 | ||
| Q4 24 | $1.00 | $-0.08 | ||
| Q3 24 | $0.90 | $-0.14 | ||
| Q2 24 | $0.81 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $242.8M |
| Total DebtLower is stronger | $514.4M | — |
| Stockholders' EquityBook value | $710.0M | $-500.5M |
| Total Assets | $7.0B | $501.9M |
| Debt / EquityLower = less leverage | 0.72× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $242.8M | ||
| Q3 25 | — | $257.8M | ||
| Q2 25 | — | $153.7M | ||
| Q1 25 | — | $61.6M | ||
| Q4 24 | — | $149.8M | ||
| Q3 24 | — | $130.4M | ||
| Q2 24 | — | — |
| Q1 26 | $514.4M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $710.0M | — | ||
| Q4 25 | $696.6M | $-500.5M | ||
| Q3 25 | $676.4M | $-524.3M | ||
| Q2 25 | $652.1M | $-570.7M | ||
| Q1 25 | $640.1M | $-591.4M | ||
| Q4 24 | $531.2M | $-489.1M | ||
| Q3 24 | $529.9M | $-745.1M | ||
| Q2 24 | $508.3M | — |
| Q1 26 | $7.0B | — | ||
| Q4 25 | $7.0B | $501.9M | ||
| Q3 25 | $7.0B | $519.0M | ||
| Q2 25 | $6.9B | $402.1M | ||
| Q1 25 | $7.0B | $303.8M | ||
| Q4 24 | $5.8B | $382.9M | ||
| Q3 24 | $5.7B | $364.6M | ||
| Q2 24 | $5.7B | — |
| Q1 26 | 0.72× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-70.4M |
| Free Cash FlowOCF − Capex | — | $-71.3M |
| FCF MarginFCF / Revenue | — | -186.2% |
| Capex IntensityCapex / Revenue | — | 2.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-308.8M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $63.9M | $-70.4M | ||
| Q3 25 | $36.1M | $-68.9M | ||
| Q2 25 | $6.0M | $-79.7M | ||
| Q1 25 | $1.0M | $-85.9M | ||
| Q4 24 | $60.9M | $-85.1M | ||
| Q3 24 | $-14.5M | $-98.8M | ||
| Q2 24 | $14.5M | — |
| Q1 26 | — | — | ||
| Q4 25 | $58.2M | $-71.3M | ||
| Q3 25 | $35.4M | $-69.6M | ||
| Q2 25 | $4.5M | $-80.8M | ||
| Q1 25 | $-727.0K | $-87.0M | ||
| Q4 24 | $55.4M | $-87.3M | ||
| Q3 24 | $-16.2M | $-101.6M | ||
| Q2 24 | $13.2M | — |
| Q1 26 | — | — | ||
| Q4 25 | 85.5% | -186.2% | ||
| Q3 25 | 54.1% | -217.2% | ||
| Q2 25 | 7.3% | -305.9% | ||
| Q1 25 | -1.2% | -526.9% | ||
| Q4 24 | 116.4% | -1155.4% | ||
| Q3 24 | -36.0% | -1663.2% | ||
| Q2 24 | 30.8% | — |
| Q1 26 | — | — | ||
| Q4 25 | 8.4% | 2.4% | ||
| Q3 25 | 1.1% | 2.3% | ||
| Q2 25 | 2.4% | 4.1% | ||
| Q1 25 | 2.9% | 6.8% | ||
| Q4 24 | 11.7% | 28.0% | ||
| Q3 24 | 3.8% | 45.7% | ||
| Q2 24 | 3.0% | — |
| Q1 26 | — | — | ||
| Q4 25 | 2.83× | — | ||
| Q3 25 | 1.70× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.14× | — | ||
| Q4 24 | 4.15× | — | ||
| Q3 24 | -1.11× | — | ||
| Q2 24 | 1.21× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CAC
| Net Interest Income | $52.4M | 81% |
| Noninterest Income | $12.0M | 19% |
IBRX
Segment breakdown not available.
